Armata Pharmaceuticals (ARMP) EPS (Basic) (2013 - 2026)
Armata Pharmaceuticals (ARMP) posted EPS (Basic) of -$1.84 for Q1 2026, down 295.39% sequentially from -$0.47 in Q4 2025, and down 464.29% YoY from $0.5 in Q1 2025.
Armata Pharmaceuticals (ARMP) EPS (Basic) (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals has reported EPS (Basic) for 14 years, with the latest figure at -$1.84 in Q1 2026.
- Quarterly EPS (Basic) fell 464.29% year-over-year to -$1.84 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.57 (up 11.28% YoY) and the FY2025 annual result came in at -$3.35, up 4.33% from the prior year.
- EPS (Basic) fell to -$1.84 in Q1 2026 per ARMP's latest filing, from -$0.47 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.28 in Q3 2022 and troughed at -$2.25 in Q2 2024.
- A 5-year average of -$0.75 and a median of -$0.39 in 2022 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) sank 560.06% in 2024, then surged 84.7% in 2025.
- Over 5 years, EPS (Basic) stood at -$0.3 in 2022, then slipped by 1.01% to -$0.3 in 2023, then plunged by 59.67% to -$0.49 in 2024, then climbed by 4.12% to -$0.47 in 2025, then sank by 295.39% to -$1.84 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$1.84, -$0.47, and -$1.9 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Armata Pharmaceuticals | 162.98 Mn | 138.98 Mn | - | -0.46 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.84 |
| Mar 31, 2026 | -1.84 |
| Dec 31, 2025 | -0.47 |
| Sep 30, 2025 | -1.90 |
| Jun 30, 2025 | -0.34 |
| Mar 31, 2025 | -0.33 |
| Dec 31, 2024 | -0.49 |
| Sep 30, 2024 | -2.10 |
| Jun 30, 2024 | -2.25 |
| Mar 31, 2024 | -0.37 |
| Dec 31, 2023 | -0.30 |
| Sep 30, 2023 | -0.32 |
| Jun 30, 2023 | -0.42 |
| Mar 31, 2023 | -0.46 |
| Dec 31, 2022 | -0.30 |
| Sep 30, 2022 | -0.28 |
| Jun 30, 2022 | -0.28 |
| Mar 31, 2022 | -0.39 |
| Dec 31, 2021 | -0.34 |
| Sep 30, 2021 | -0.27 |